ON STABILITY OF A COMBINED GLEEVEC AND IMMUNE MODEL IN CHRONIC LEUKEMIA: EXPLOITING DELAY SYSTEM STRUCTURE
暂无分享,去创建一个
[1] L. Saveanu,et al. Ex Vivo Characterization of Multiepitopic Tumor-Specific CD8 T Cells in Patients with Chronic Myeloid Leukemia: Implications for Vaccine Development and Adoptive Cellular Immunotherapy1 , 2005, The Journal of Immunology.
[2] Doron Levy,et al. Post-transplantation dynamics of the immune response to chronic myelogenous leukemia. , 2005, Journal of theoretical biology.
[3] Doron Levy,et al. Dynamics and Potential Impact of the Immune Response to Chronic Myelogenous Leukemia , 2008, PLoS Comput. Biol..
[4] S J Lee. CHRONIC MYELOGENOUS LEUKAEMIA , 2000, British journal of haematology.
[5] Carl T. Bergstrom,et al. Models of CD8+ responses: 1. What is the antigen-independent proliferation program. , 2003, Journal of theoretical biology.
[6] Daniel Isnardon,et al. Imatinib and plasmacytoid dendritic cell function in patients with chronic myeloid leukemia. , 2004, Blood.
[7] Tatsuo Furukawa,et al. The effects of STI571 on antigen presentation of dendritic cells generated from patients with chronic myelogenous leukemia , 2003, Hematological oncology.
[8] Brent Neiman,et al. A Mathematical Model of Chronic Myelogenous Leukemia , 2000 .
[9] Richard J. Jones,et al. Treatment options for chronic myeloid leukemia: imatinib versus interferon versus allogeneic transplant , 2004, Current opinion in oncology.
[10] P. Klenerman,et al. Low level viral persistence after infection with LCMV: a quantitative insight through numerical bifurcation analysis. , 2001, Mathematical biosciences.
[11] Martin A. Nowak,et al. Dynamics of chronic myeloid leukaemia , 2005, Nature.
[12] Susan O'Brien,et al. Molecular Responses in Patients with Chronic Myelogenous Leukemia in Chronic Phase Treated with Imatinib Mesylate , 2005, Clinical Cancer Research.
[13] Alan S. Perelson,et al. Different Dynamics of CD4+ and CD8+ T Cell Responses During and After Acute Lymphocytic Choriomeningitis Virus Infection 1 , 2003, The Journal of Immunology.
[14] Helen Moore,et al. A mathematical model for chronic myelogenous leukemia (CML) and T cell interaction. , 2004, Journal of theoretical biology.